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Abstract
Background Overweight/obesity in patients after total hip
arthroplasty (THA) is a growing problem and is associated
with postoperative complications and a negative effect on
functional outcome. The objective of this study is to
determine to what extent overweight/obesity is associated
with physical functioning and health-related quality of life
1 year after primary THA.
Methods A retrospective analysis of prospectively collected
data from 653 patients who had undergone a primary THA
was conducted. Physical functioning, health-related quality of
life, body mass index (BMI), comorbidity, and postoperative
complications were assessed by means of a questionnaire and
from medical records. To determine to what extent over-
weight/obesity is associated with physical functioning and
health-related quality of life after THA, a structural equation
model (SEM) analysis was conducted.
Results The association of BMI corrected for age, gender,
complications, and comorbidity with physical functioning
is −0.63. This means that an increase in 1 kg/m
2 BMI leads
to a reduction of 0.63 points in the physical functioning
score as measured with the Western Ontario and McMaster
Universities Osteoarthritis Index (100-point scale). The
prevalence of complications or comorbidity leads to a
reduction of, respectively, 5.63 and 7.25 (one or two
comorbidities) and 14.50 points in the case of more than
two comorbidities on the physical functioning score. The
same pattern is observed for health-related quality of life.
Conclusions Theinfluenceofoverweight/obesityonphysical
functioning and health-related quality of life is low. The
impact of complications and comorbidity is considerable.
Refusing a patient a THA solely on the basis of overweight or
obesity does not seem justified.
Keywords Obesity.Total hip arthroplasty.Quality of life.
Physical functioning
Introduction
Osteoarthrosis (OA) of the hip is one of the most prevalent
age-related musculoskeletal conditions, leading to a signifi-
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DOI 10.1007/s11695-011-0483-1cant impairment in patients’ ability to perform activities of
dailylivingandhavingalargeimpactonhealth-relatedquality
of life [1, 2]. In the US population, symptomatic OA of the
hip is reported to affect 8.7% of men and 9.3% of women
aged 45 years or older [3]. Among the Dutch population,
these prevalences were 2.5% for men and 5.0% for women
in 2000 [4]. Total hip arthroplasty (THA) is a highly
successful and widely applied treatment for advanced OA
of the hip, with 202,500 primary THAs performed in the US
in 2003 [5] and 20,266 in the Netherlands in 2008 [6].
In the year 2006, an estimated 40% of adults aged over
65 in the US general population were overweight, and
another 22% were obese [7]. In the Dutch general
population, almost 57% of adults over age 65 were
overweight in 2006, while 14% were obese [8]. Overweight
is also a growing problem in patients after a THA.
Overweight/obesity is associated with a negative effect on
functional outcome after THA and on implant longevity. It
can affect polyethylene wear negatively. Studies have also
found a correlation between obesity and higher infection
rates and risk of dislocation, aseptic loosening, and revision
[9–12]. Moreover, with respect to general health, over-
weight/obesity is considered a risk factor for hypertension,
type 2 diabetes, coronary heart disease, stroke, gallbladder
disease, respiratory problems, and some forms of cancer
(National Institutes of Health) [13]. The World Health
Organization considers obesity as a chronic disease [14].
Limited research has been conducted so far into the
potentially negative effect of overweight/obesity on functional
outcomeandhealth-relatedquality oflife afterTHA [9]. Based
on the scarce research done, it is difficult to draw uniform
conclusions, as different instruments, points in time, and
perspectives (physician-based vs. patient-based) have been
used [15–22]. Moreover, for research conducted into the
effect of overweight/obesity on functional outcome and
health-related quality of life after THA, one must ask whether
comorbidity and complications also have to be taken into
account [21]. As mentioned, overweight and obesity are
associated with a variety of additional health problems, and
the same applies for postoperative complications.
Few studies have taken the influence of comorbidity and
complications into account when assessing the influence of
overweight/obesity on patient-perceived physical function-
ing and health-related quality of life. Therefore, the aim of
the current study is to analyze the effect of overweight/
obesity on patient-perceived physical functioning and
health-related quality of life 1 year after THA. As
overweight/obesity is considered one of the risk factors
for a spectrum of comorbidity and postoperative complica-
tions, the additional effect on physical functioning and
health-related quality of life of comorbidity and postoper-
ative complications in combination with overweight/obesity
was analyzed.
Materials and Methods
Subjects
A retrospective analysis was done on prospectively collect-
ed data. Data were collected in three orthopedic centers
(one university medical center, two regional hospitals) in
the Netherlands. All patients who had undergone an
elective primary THA because of primary OA of the hip
between February 2005 and January 2007 were consecu-
tively included. Patients who had died at the time of follow-
up, who had other lower-limb arthroplasties performed in
the period of follow-up, or who had cognitive limitations
were excluded. Patients were sent a self-report question-
naire with an explanatory letter 1 year postoperatively
(mean, 52.4 weeks; SD, 3.9 weeks).
Surgery was performed by 15 staff surgeons or under
direct supervision of one of these surgeons. Patients were
operated on using a posterolateral or anterolateral approach.
This approach was surgeon-specific, with each surgeon
using the same approach consistently for all THAs
performed during the study period. Different types of
implants and fixation types were used. Patients were
allowed full weight bearing the second day after surgery,
using crutches during the first three postoperative months.
The study was approved and conducted in accordance
with the regulations of the medical ethical boards of the
participating hospitals. Patients were informed in the
explanatory letter that return of the completed questionnaire
would be taken as consent to participate.
Instruments
To measure patient-perceived physical functioning, the
Dutch-language version of the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)
was used [23, 24]. The WOMAC is a widely used
disease-specific questionnaire for measuring outcome after
THA [25]. Using a Likert scale, individuals rate themselves
on multiple items grouped into three domains: pain (5
items), stiffness (2 items), and physical functioning (17
items). The scores of the subscales make up the total score.
The total score of 96 points is recoded into a 100-point
scale, with a higher score representing better physical
functioning. To get an impression of health-related quality
of life, the subscale of self-perceived general health of the
Short-Form 36 health survey (SF-36) was used [26].
General comorbidity was measured with the 12-item list
from Nilsdotter [27]. Patients were rated as having no
complications, one or two complications, or more than two.
Body mass (in kilograms) and height (in meters) were self-
reported. Body mass index (BMI) was calculated by
dividing body mass in kilograms by height in square
524 OBES SURG (2012) 22:523–529meters. A BMI <25 kg/m
2 was considered normal weight,
between 25 and 30 kg/m
2 overweight, and >30 kg/m
2
obese. Age, gender, and complications (perioperative and
postoperative) were extracted from the medical records.
Statistical Analysis
Statistical analyses were performed using the SPSS 16 software
(SPSSInc,233S.WackerDrive,Chicago,IL60606,USA)and
Mp lu sv e rs io n5[ 28]. Descriptive statistics were used to depict
the main characteristics of the patients. ANOVA with
Bonferroni adjustment was used to compare continuous
variables between the three BMI groups (BMI <25 kg/m
2,
BMI 25–30 kg/m
2, and BMI >30 kg/m
2). To determine to
what extent overweight/obesity (independent variable) is
predictive of patient-perceived physical functioning
(WOMAC total score) and self-perceived general health
(dependent variables), linear regression analysis was used. In
addition, comorbidity (no, one to two, >2; no comorbidity =
ref.) and complications (yes/no; no = ref.) were included as
dummy variables in the analyses to correct for their influence.
A p value of <0.05 was considered statistically significant.
The linear regression analysis was performed with a
structural equation model (SEM) technique in order to
determine to what extent overweight/obesity is associated
with patient-perceived physical functioning and self-
perceived general health after THA. Dependent variables
were patient-perceived physical functioning and self-
perceived general health. Independent variables were
BMI, age, gender, complications, and comorbidity. BMI
was centered at 25 as being the upper limit of a healthy
weight and age at 70 years (the mean age of this study
population). In addition, based on the SEM, the correlation
of the two dependent variables was calculated.
Results
Of the 848 eligible patients, 653 (77.0%) returned complete
questionnaires and were included. There were 484 female
patients (74.1%). Mean age at surgery was 70.3 years (SD,
8.2 years; Table 1). Mean BMI of the patients was 27.0 kg/
m
2 (SD, 4.1 kg/m
2). Most of the patients lived with a
partner (59.1%) and had a lower educational level (49.3%;
Table 1). A total of 181 patients (27.7%) reported no
additional comorbidity, 263 patients (40.3%) one to two
comorbidities, and 209 patients (32.0%) more than two
comorbidities. Complications occurred in 47 (7.2%)
patients. There were eight (1.2%) dislocations, three
(0.5%) sciatic nerve palsies, three (0.5%) superior gluteal
nerve palsies, two (0.3%) periprosthetic fractures, and two
(0.3%) malpositioned prostheses necessitating revision
surgery.
Patients did not differ with respect to mean age at
surgery, comorbidity, or complications between the three
BMI categories. With respect to gender, there were
significantly more women in the BMI <25 group.
In order to determine to what extent overweight/obesity
influences patient-perceived physical functioning and self-
perceived general health after THA, an SEM analysis was
conducted. The model had four steps. The first step/model
determined the association of BMI with patient-perceived
physical functioning and self-perceived general health,
while the second model determined the independent effect
of age and gender. In the third step/model, the effect of
BMI, age, and gender were added into the model. In the
final step (model 4), comorbidity and complications were
added to estimate their additional effect (Table 2).
The influence of BMI on patient-perceived physical
functioning and self-perceived general health as depicted in
Total, N=543–653 BMI <25,
N=191–217
BMI 25–30,
N=229–275
BMI >30,
N=111–137
Age, mean (SD) 70.3 (8.2) 70.8 (8.8) 70.1 (8.0) 69.5 (7.8)
Gender (% women) 74.2 80.3 68.9 73.0
Education, mean (%)
Lower 322 (54.8) 87 (43.3) 147 (58.6) 77 (62.6)
Secondary 201 (34.2) 88 (43.8) 72 (28.7) 40 (32.5)
Higher 65 (11.1) 26 (12.9) 32 (12.7) 6 (9.0)
BMI, mean (SD) 27.0 (4.1) 22.9 (1.7) 27.2 (1.3) 33.0 (2.9)
Comorbidity, mean (%)
None 181 (27.7) 50 (23.5) 77 (28.0) 36 (26.3)
1–2 263 (40.3) 98 (46.0) 111 (40.4) 50 (36.5)
>2 209 (32.0) 65 (30.5) 87 (31.6) 51 (37.2)
Complications, mean (%)
Yes 47 (7.2) 13 (6.2) 25 (9.1) 9 (6.6)
No 603 (92.8) 198 (93.8) 249 (90.9) 128 (93.4)
Table 1 Baseline characteristics
of the study population
OBES SURG (2012) 22:523–529 525model 1 (Table 2)w a s−0.35 (p=0.07) and −0.59 (p=0.001),
respectively. This means that, with every increase of 1 kg/m
2
BMI, the score on patient-perceived physical functioning as
measured with the WOMAC (100-point scale) is reduced by
0.35 and on the self-perceived general health subscale of the
SF-36 (100-point scale) by 0.59 points. In model 2, the
separate influence of age and gender are reported; in model
3, in combination with BMI. In both models, the influence of
gender on patient-perceived physical functioning is distinct
(respectively, −3.88 (p=0.02) and −4.53 (p=0.01)). Finally,
model 4 reports the influence of BMI corrected not only for
age and gender but also for complications and comorbidity.
With respect to patient-perceived physical functioning, every
increase in 1 kg/m
2 BMI leads to a reduction of 0.63 points
on the WOMAC score (p=0.001). By contrast, the preva-
lence of complications or comorbidity leads to a reduction
of, respectively, 5.63 (p=<0.001) and 7.25 (p=0.01) points
on the WOMAC score in the case of one or two
comorbidities and a reduction of 14.50 points on the
WOMAC score in the case of more than two comorbidities.
With respect to the self-perceived general health of the SF-
36, the same pattern is seen, although the influence of gender
is less prominent. The correlation between the two dependent
variables, patient-perceived physical functioning and self-
perceived general health, is 0.35 in the last model. The R
2 for
these last models was 0.10 for patient-perceived physical
functioning and 0.13 for self-perceived general health, which
implies that 10% and 13% of the variance could be explained
(data not shown).
Discussion
It is generally considered that overweight/obesity is
associated with a negative effect on outcome after THA
and on implant longevity. From the results of our study, it
can be concluded that the influence of overweight/obesity
on patient-perceived physical functioning and self-
perceived general health is low, both without and with
correction for the other covariables. The sole influence of
1 kg/m
2 increase in BMI leads to a reduction in the score on
patient-perceived physical functioning as measured with the
WOMAC by 0.35 points and on self-perceived general
health as determined with the SF-36 by 0.59 points. This
implies that, compared to a person with a BMI of 25 kg/m
2,
someone with a BMI of 35 kg/m
2 of the same age and
gender has a reduction in score on physical functioning and
health-related quality of life of, respectively, 3.5 and 5.9
points. Corrected for the influence of complications,
comorbidity, and the demographic variables, the influence
of BMI remains more or less the same. On the other hand,
the influence of complications is considerable and leads to a
reduction in the physical functioning score of 5.63 points
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526 OBES SURG (2012) 22:523–529and health-related quality of life of 8.19 points. For
comorbidity, the same pattern is seen with a reduction of
7.25 points for one or two comorbidities and 14.50 points
for more than two comorbidities on the physical function-
ing score and a comparable effect on health-related quality
of life with a reduction of, respectively, 7.02 and 14.04
points.
The question thus arises as to whether these effects can
be considered clinically relevant. Angst et al. [29] report
that differences larger than 6% of the maximum score on
the WOMAC (96/100 points) and SF-36 (100 points) can
be considered clinically relevant. With the exception of
more than two comorbidities (reduction of 14.04 points on
the SF-36 health perception scale), none of the variables
lead to a relevant effect on their own, yet the combination
of factors can rapidly lead to relevant differences. For
example, being a woman in combination with a BMI of
30 kg/m
2 and one or two comorbidities already leads to a
clinically relevant effect on the physical functioning score.
Still, overall, it can be stated that the sole effect of BMI on
physical functioning and health-related quality of life is low
and will only lead to a clinically relevant effect in extreme
situations. On the other hand, the effects of comorbidity and
complications are substantial.
Based on the aforementioned results, it can be argued
that, in future research, comorbidity and complications have
to be taken into account, otherwise an incorrect and
incomplete picture is obtained. Until now, only a few
studies have taken comorbidity and complications into
account when assessing the influence of overweight/obesity
on physical functioning and health-related quality of life.
The findings of our study are in line with research by
Kessler and Käfer [16], McCalden et al. [17], Moran et al.
[18], Stickles et al. [19], and Andrew et al. [20]. Kessler
and Käfer used the WOMAC as outcome measure. They
concluded that overweight/obesity is of no influence, yet
they measured 10 days and 3 months postoperatively.
McCalden et al. [17] measured after a mean period of
8.4 years postoperatively and concluded that morbid
obesity does not affect the postoperative outcome after
THA as measured with the WOMAC, SF-12, and Harris
Hip Score (HHS). Moran et al. [18] concluded that BMI did
not lead to clinically relevant effects on the postoperative
HHS and SF-36. Unlike the aforementioned studies, Moran
et al. took both complications and comorbidity into
account. However, it must be mentioned that we used a
patient-based outcome (WOMAC) and Moran et al. used a
physician-based outcome (HHS). Additionally, Stickles et
al. [19] and Andrew et al. [20] concluded that obese
patients enjoy as much improvement and satisfaction as
non-obese patients. Stickles et al. found that there were
no significant differences between obese and non-obese
patients with respect to their improvement on the
WOMAC score and the Physical Component and
Mental Component scores of the SF-36. Andrew et al.
concluded that there was no difference in the change in
the Oxford Hip Score between obese and non-obese
patients 5 years postoperatively.
It can be concluded that the results of our study are
contrary to results reported by Busato et al. [21], who
measured the effect of a high BMI on functional outcome in
a cohort of 18,968 patients. They found that a high BMI is
associated with decreased ambulation during a follow-up
period of 15 years. By contrast, we measured only 1 year
postoperatively, and our good results at that point do not
rule out deterioration later on. Comparing our results with
those of the study of Jackson et al. [22] leads to a mixed
picture: they found a significant difference between obese
and non-obese patients in favor of the non-obese group
with respect to the postoperative HHS. And yet, they found
no difference between the two groups in overall satisfaction
with surgery.
Finally, it can be concluded that, with the exception of
the Moran study, none of these studies takes the additional
effect of comorbidity into account. The substantial impact
of comorbidity found in our study is in line with
suggestions stated in a research by Braeken et al. [15],
who argued that more attention should be paid in future
research to the potentially negative influence of comorbidity
on physical functioning after THA.
Once again, a strength of our study is that not only the
influence of overweight and obesity were taken into
account but also the influence of additional comorbidity
and postoperative complications. Additional strong points
of our study are the size of our study group and the
response rate of 77.0%. In order to get an impression of the
representativeness of our study group, we determined the
response rate by BMI category. As the BMI of the
nonresponders was not available 1 year after THA, we
used the BMI (of both responders and nonresponders) that
was determined when the patients were admitted to the
hospital for surgery. Divided by BMI category, the response
rate was, respectively, 76.0% (BMI <25 kg/m
2), 81.5%
(BMI 25–30 kg/m
2), and 71.1% (BMI >30 kg/m
2). From
this, it can be concluded that no response bias was present.
A weak point is that height and weight and thus BMI were
self-reported. This probably leads to an underestimation of
the problem, as it is known that people tend to underesti-
mate their weight and overestimate their height [30].
Secondly, we used the 12-item list from Nilsdotter [27]t o
get an impression of the presence of comorbidity. It can be
argued that not all comorbidities are included in this
instrument. On the other hand, the most prevalent comor-
bidities or health problems associated with overweight/
obesity, like heart disease, hypertension, peripheral artery
disease, diabetes, and cancer, are included in this instru-
OBES SURG (2012) 22:523–529 527ment. Finally, our study was limited to the patients’ 1-year
postoperative status. The long-term influence of over-
weight/obesity on patient-perceived physical functioning,
health-related quality of life, and prosthetic longevity could
not be determined. This latter point needs particular
attention, as the present study used self-reported instru-
ments and consequently no objective information was
gathered about the effect of overweight on the prosthesis.
Conclusions
Overall, it can be concluded that the influence of
overweight/obesity on physical functioning and health-
related quality of life both with and without correcting for
the other covariables is low. On the other hand, the impact
of complications and comorbidity is considerable. Espe-
cially the combination of factors can rapidly lead to
clinically relevant differences. In that sense, it can be
concluded that future research into the effect of obesity/
comorbidity on physical functioning and health-related
quality of life must take comorbidity and complications
into account, otherwise an incorrect and incomplete picture
is obtained. Finally, based on the results of this study, it can
be concluded that refusing a patient a THA solely on the
basis of overweight or obesity seems unjustified.
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